Cancerous tumors carry certain genetic markers called neoantigens and Facebook billionaire Sean Parker wants to use algorithms to find them.
To do so, the Sean Parker Institute for Cancer Immunotherapy will work with more than 30 public and private pharmaceutical, biotech, cancer research nonprofits and academic institutions through a partnership with the Cancer Research Institute to use… Read More...